Featured Content
Consensus Statement
08/25/2026
Rebecca Mashaw
The Rome Foundation and IOIBD developed consensus recommendations for the identifying and managing IBS-like symptoms among patients with IBD but without uncontrolled inflammation.
The Rome Foundation and IOIBD developed consensus recommendations for the identifying and managing IBS-like symptoms among patients with IBD but without uncontrolled inflammation.
The Rome Foundation and IOIBD...
08/25/2026
Advances in Inflammatory Bowel Disease Network
Research
07/23/2026
Rebecca Mashaw
Investigators evaluated dietary patterns among more than 124,000 adults across 21 countries and found that higher consumption of ultraprocessed grains was associated with a significantly increased risk of developing Crohn’s disease or...
Investigators evaluated dietary patterns among more than 124,000 adults across 21 countries and found that higher consumption of ultraprocessed grains was associated with a significantly increased risk of developing Crohn’s disease or...
Investigators evaluated dietary...
07/23/2026
Advances in Inflammatory Bowel Disease Network
Research Review
07/20/2026
Jessica Garlewicz
Researchers found distinct differences in disease presentation among patients with late-onset Crohn's disease and ulcerative colitis, and variations in the biologics used for these patients compared to those with earlier onset.
Researchers found distinct differences in disease presentation among patients with late-onset Crohn's disease and ulcerative colitis, and variations in the biologics used for these patients compared to those with earlier onset.
Researchers found distinct...
07/20/2026
Advances in Inflammatory Bowel Disease Network
Research Report
07/01/2026
Rebecca Mashaw
Investigators found that GLP-1 RA use was consistently associated with lower incidence of colorectal cancer across patients with inflammatory bowel, including a subset with concomitant type 2 diabetes mellitus.
Investigators found that GLP-1 RA use was consistently associated with lower incidence of colorectal cancer across patients with inflammatory bowel, including a subset with concomitant type 2 diabetes mellitus.
Investigators found that GLP-1...
07/01/2026
Advances in Inflammatory Bowel Disease Network
Research Insights
07/01/2026
Rebecca Mashaw
Investigators conclude that adequately powered randomized trials with standardized efficacy and long-term safety outcomes are needed before ACT can be more broadly incorporated into routine IBD management.
Investigators conclude that adequately powered randomized trials with standardized efficacy and long-term safety outcomes are needed before ACT can be more broadly incorporated into routine IBD management.
Investigators conclude that...
07/01/2026
Advances in Inflammatory Bowel Disease Network
Research Review
05/15/2026
Jessica Garlewicz
Although the study was not powered to detect statistical significance, the findings suggest a potential benefit of incorporating drug levels into routine management.
Although the study was not powered to detect statistical significance, the findings suggest a potential benefit of incorporating drug levels into routine management.
Although the study was not...
05/15/2026
Advances in Inflammatory Bowel Disease Network
Research Summary
05/07/2026
Jessica Garlewicz
Sustained therapy did not appear to introduce cumulative risk, supporting continued use in patients requiring maintenance treatment.
Sustained therapy did not appear to introduce cumulative risk, supporting continued use in patients requiring maintenance treatment.
Sustained therapy did not appear...
05/07/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
05/06/2026
Jessica Garlewicz
In ulcerative colitis, GLP-1 RA use was associated with reductions in the use of corticosteroids and acute care utilization.
In ulcerative colitis, GLP-1 RA use was associated with reductions in the use of corticosteroids and acute care utilization.
In ulcerative colitis, GLP-1 RA...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
05/06/2026
Jessica Garlewicz
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
04/15/2026
Rebecca Mashaw
The authors noted that while clinician engagement improved, consistent integration into routine care workflows was not achieved and absolute rates of treat-to-target adoption remained low.
The authors noted that while clinician engagement improved, consistent integration into routine care workflows was not achieved and absolute rates of treat-to-target adoption remained low.
The authors noted that while...
04/15/2026
Advances in Inflammatory Bowel Disease Network
Research Review
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
From Gastroenterology